|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-1-10
|
|
pubmed:abstractText |
Children <4 years of age (yo) with malignant central nervous system (CNS) tumors have a dismal prognosis. In an attempt to delay or obviate radiation therapy (XRT) and improve outcome, our institution has treated children <4 yo with newly diagnosed malignant CNS tumors with high-dose chemotherapy (HDC) and autologous stem cell rescue (ASCR) followed by selective XRT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1545-5009
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2006 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
278-84
|
|
pubmed:dateRevised |
2009-1-12
|
|
pubmed:meshHeading |
pubmed-meshheading:16456857-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16456857-Brain Neoplasms,
pubmed-meshheading:16456857-Carboplatin,
pubmed-meshheading:16456857-Child, Preschool,
pubmed-meshheading:16456857-Cisplatin,
pubmed-meshheading:16456857-Cognition Disorders,
pubmed-meshheading:16456857-Cranial Irradiation,
pubmed-meshheading:16456857-Cyclophosphamide,
pubmed-meshheading:16456857-Developmental Disabilities,
pubmed-meshheading:16456857-Disease-Free Survival,
pubmed-meshheading:16456857-Ependymoma,
pubmed-meshheading:16456857-Etoposide,
pubmed-meshheading:16456857-Follow-Up Studies,
pubmed-meshheading:16456857-Ganglioglioma,
pubmed-meshheading:16456857-Glioma,
pubmed-meshheading:16456857-Humans,
pubmed-meshheading:16456857-Infant,
pubmed-meshheading:16456857-Medulloblastoma,
pubmed-meshheading:16456857-Mitotic Index,
pubmed-meshheading:16456857-Neuroectodermal Tumors, Primitive,
pubmed-meshheading:16456857-Oligodendroglioma,
pubmed-meshheading:16456857-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:16456857-Quadriplegia,
pubmed-meshheading:16456857-Retrospective Studies,
pubmed-meshheading:16456857-Sensation Disorders,
pubmed-meshheading:16456857-Spinal Cord Neoplasms,
pubmed-meshheading:16456857-Thiotepa,
pubmed-meshheading:16456857-Transplantation, Autologous,
pubmed-meshheading:16456857-Treatment Outcome,
pubmed-meshheading:16456857-Vincristine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
|
|
pubmed:affiliation |
Division of Hematology and Oncology, Children's National Medical Center, Washington, District of Columbia, USA.
|
|
pubmed:publicationType |
Journal Article
|
